Exempel: Heart Attack

Sök i kliniska prövningar för: N-Methylaspartate

Totalt 193 resultat

NCT01722578

Avslutad

L-ornithine L-aspartate in Overt Hepatic Encephalopathy

Villkor: Cirrhosis of Liver; Hepatic Encephalopathy
NCT00896831

Okänd status

Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy

Villkor: Hepatic Encephalopathy
NCT00740142

Avslutad

Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy

Villkor: Hepatic Encephalopathy
NCT00142233

Avslutad

EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis

Villkor: Pancreatitis
NCT00470314

Okänd status

Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure

Villkor: Acute Liver Failure
NCT01440829

Avslutad

The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS

Villkor: Decompensated Cirrhosis; Portal Hypertension; Bleeding Varices; Refractory Ascites
NCT01041755

Avslutad

Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.

Villkor: Hepatic Encephalopathy
NCT00433368

Avslutad

Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy

Villkor: Hepatic Encephalopathy
NCT03228524

Rekrytering

D-aspartate and Therapeutic Exercise

Villkor: Brain Injuries
NCT02158182

Avslutad

Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding

Villkor: Hepatic Encephalopathy
NCT03387046

Avslutad

A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS)

Villkor: Multiple Sclerosis, Relapsing-Remitting
NCT00785811

Avslutad

Effect of Chronic Supplementation of L-arginine in the Muscular Performance

Villkor: Muscular Fatigue
NCT02523703

Avslutad

Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot Study

Villkor: Multiple Sclerosis
NCT00305591

Avslutad

Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.

Villkor: Cirrhosis; Hepatic Encephalopathy
NCT01847651

Avslutad

Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate

Villkor: Hepatic Encephalopathy; Minimal Hepatic Encephalopathy; Cirrhosis
NCT03580122

Avslutad

The Effect of Arginine on Classic Galactosemia

Villkor: Classic Galactosemia
NCT03562585

Avslutad

Immunological Measurement of Aspartate/Alanine Aminotransferase

Villkor: Chronic Liver Disease and Cirrhosis
NCT00854425

Avslutad

L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma

Villkor: Lymphoma
NCT03524651

Rekrytering

Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia

Villkor: Iron Deficiency Anemia
NCT01047592

Avslutad

Treatment of N-methyl-D-aspartate (NMDA) Enhancers for Schizophrenia

Villkor: Schizophrenia
NCT00933673

Okänd status

New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma

Villkor: Lymphoma
NCT03212521

Avslutad

Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1

Villkor: Hepatitis C Virus (HCV)
NCT00486902

Avslutad

Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?

Villkor: Ketamine Adverse Reaction; Effects of; Anesthesia, Spinal and Epidural, in Pregnancy; Complication of Labor and/or Delivery
NCT02051426

Avslutad

Behavioral and Cognitive Effects of the N-methyl-D-aspartate Receptor (NMDAR) Co-agonist D-serine in Healthy Humans

Villkor: Healthy
NCT01553435

Okänd status

Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients

Villkor: Pain; Opioid Tolerance; Analgesia Tolerance